A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck.
about
Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockadeDentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2.Multivariate meta-analysis: potential and promise.Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.Comparative study of the behavior of p53 immunoexpression in smoking associated lesions: Reinke's edema and laryngeal carcinoma.Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PETHPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer PatientsPrognostic value of some tumor markers in unresectable stage IV oropharyngeal carcinoma patients treated with concomitant radiochemotherapy.Unexpected predictor-outcome associations in clinical prediction research: causes and solutions.p53 as a prognostic marker associated with the risk of mortality for oral squamous cell carcinomaMolecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome.An overview of the molecular pathology of head and neck cancer, and its clinical implications.Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma.Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients.Histological and immunohistochemical study of the expression of p53 and ki-67 proteins in the mucosa of the tongue, pharynx and larynx of rats exposed to cigarette smoke.Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53.PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome.The significance of p53 immunoexpression with different clones (DO-7 and PAb-240) in oral squamous cell carcinoma.Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors.Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.In oral squamous cell carcinoma, high FAK expression is correlated with low P53 expression.Can Imaging Parameters Provide Information Regarding Histopathology in Head and Neck Squamous Cell Carcinoma? A Meta-Analysis.Combined Metabolo-Volumetric Parameters of F-FDG-PET and MRI Can Predict Tumor Cellularity, Ki67 Level and Expression of HIF 1alpha in Head and Neck Squamous Cell Carcinoma: A Pilot StudyPossible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma
P2860
Q28539684-8EB5C2B1-AB0E-43A9-B355-6DF170AA0718Q33754437-F08E0C49-06D8-4282-90AF-5D6BFA4862AAQ33804037-CC9AFFF5-931F-4A16-B1E8-BA3C353A4696Q34501943-939EC3A7-3455-4A76-AA64-860E249F2353Q34537901-F4F0B92B-8ACF-4424-BD86-BF02BA4F0E89Q34611044-FE943978-B111-4AE4-B694-7C5037CD84F8Q35475401-E87FFC05-F919-4833-B3DB-DAAFC5B0884FQ36191292-643C1AB1-D683-4806-922F-7A6BADDFA19EQ36490386-3395F9BE-F8D0-4C9C-AC13-9189A3D7CA35Q37001478-9C090430-8D37-4911-87B3-9ED208D2BE73Q37108701-1096AAB0-6EC8-487F-A9DA-5E3D40A04A7CQ37283961-F8A945A6-16A5-479E-A51F-40EDC34EA2DCQ37703394-5FF9BB94-9403-4C7E-A0E7-BFD686C3A67BQ37903910-28FEB8A5-4CAE-430D-BADD-FBB5E70D634CQ38263740-92435A11-04F5-439E-94C3-42B4194F843EQ38388575-85738576-34DE-4258-93E8-067CF2C3A09FQ42263612-8D64404E-69D0-4371-9A75-2904F979F59DQ42512285-5DEE3A86-8BFA-4C17-AED8-027505BC7F33Q42722283-B9624437-8DD2-4CEA-8616-2FB653F7D0B0Q44476983-890A301A-3E2B-4ACC-8FFA-7334BFDC832CQ46641290-6C2632CA-E48D-480A-83EF-264B5B32C142Q53264115-2C911DC2-F13E-409B-911E-A5EBEDD864A7Q54363778-AD1D6973-25D2-4A77-B7DB-3BE7F079CBE7Q54497749-B5CA4FE4-3791-4348-B455-90D07C89883CQ55279713-ACD94530-AE25-4B82-8004-764E26C7AB57Q58725990-5FE27EA5-5D16-49FC-8B26-EFBEF79E47BAQ58851158-65E1AEBC-1765-4056-AC0E-0F5C5925DE3F
P2860
A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A systematic review of p53 as ...... subsites of the head and neck.
@en
A systematic review of p53 as ...... subsites of the head and neck.
@nl
type
label
A systematic review of p53 as ...... subsites of the head and neck.
@en
A systematic review of p53 as ...... subsites of the head and neck.
@nl
prefLabel
A systematic review of p53 as ...... subsites of the head and neck.
@en
A systematic review of p53 as ...... subsites of the head and neck.
@nl
P2093
P2860
P1476
A systematic review of p53 as ...... subsites of the head and neck.
@en
P2093
Catrin Tudur-Smith
Mark T Boyd
Richard D Riley
Sankalap Tandon
Terence M Jones
P2860
P304
P356
10.1158/1055-9965.EPI-09-0981
P577
2010-02-01T00:00:00Z